Osteonecrosis of the hip: novel approaches to evaluation and treatment

Frank A Petrigliano1, Jay R Lieberman

  • 1Department of Orthopaedic Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA. fpetrigliano@mednet.ucla.edu

Insights

Treating osteonecrosis of the hip is challenging. Research explores genetic factors, advanced imaging, and new therapies like core decompression and hip replacement to improve patient outcomes.

Area of Science:

  • Orthopedics
  • Regenerative Medicine
  • Genetics

Background:

  • Osteonecrosis of the hip presents complex treatment challenges.
  • Understanding the molecular basis and genetic predispositions is crucial for early diagnosis and targeted therapies.
  • Current diagnostic and therapeutic strategies require further refinement.

Purpose of the Study:

  • To review contemporary research on the molecular etiology, diagnosis, and treatment of osteonecrosis of the hip.
  • To evaluate emerging pharmacologic, biophysical, and surgical interventions.
  • To provide evidence-based recommendations for managing precollapse and advanced osteonecrosis of the hip.

Main Methods:

  • Review of current scientific literature on osteonecrosis of the hip.
  • Analysis of genetic polymorphisms associated with disease predisposition.
  • Evaluation of advanced magnetic resonance imaging (MRI) for staging.
  • Assessment of novel nonoperative and operative treatment modalities, including pharmacologic agents, biophysical treatments, bone grafting, core decompression, total hip arthroplasty, and surface replacement.

Main Results:

  • Genetic polymorphisms may enable early diagnosis and treatment of at-risk individuals.
  • Advanced MRI improves patient staging and correlates with clinical outcomes.
  • Pharmacologic and biophysical treatments show promise in delaying or preventing the progression of precollapse lesions.
  • New bone grafting techniques may enhance core decompression outcomes.
  • Surface replacement arthroplasty offers satisfactory short-term results and bone preservation in younger patients.

Conclusions:

  • Further research is necessary to validate emerging treatments for hip osteonecrosis.
  • Core decompression with or without bone grafting is recommended for precollapse lesions pending further evidence.
  • Total hip arthroplasty or surface replacement is advised for advanced disease stages.

Related Concept Videos